Weber Capital Management LLC /Adv Harvard Bioscience Inc Transaction History
Weber Capital Management LLC /Adv
- $106 Billion
- Q4 2025
A detailed history of Weber Capital Management LLC /Adv transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Weber Capital Management LLC /Adv holds 3,200,380 shares of HBIO stock, worth $2.08 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
3,200,380Holding current value
$2.08 Million% of portfolio
2.02%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
62Shares Held
19MCall Options Held
54KPut Options Held
0-
Amh Equity LTD4.05MShares$2.63 Million2.46% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.85 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.05MShares$1.33 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.25 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$695,2980.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $27.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...